Walleye Trading’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-799
Closed -$72.3K 5876
2021
Q2
$72K Buy
+799
New +$67.5K ﹤0.01% 4506
2018
Q4
Sell
-1,106
Closed -$57K 5494
2018
Q3
$57K Buy
+1,106
New +$54.2K ﹤0.01% 4494
2017
Q3
Sell
-1,640
Closed -$96 4715
2017
Q2
$96 Buy
+1,640
New +$85.2K ﹤0.01% 3572
2016
Q4
Sell
-20,668
Closed -$921K 5314
2016
Q3
$921K Buy
20,668
+11,630
+129% +$504K 0.01% 1606
2016
Q2
$345K Buy
9,038
+7,034
+351% +$309K ﹤0.01% 2535
2016
Q1
$83K Sell
2,004
-3,296
-62% -$136K ﹤0.01% 3497
2015
Q4
$257K Buy
+5,300
New +$236K ﹤0.01% 2474

Other funds holding SYNH

Walleye Trading's SYNH Position: Q3 2021 in Review

Walleye Trading sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2021, closing a stake of 799 shares — an estimated $72.3K sold.

Walleye Trading first reported a position in SYNH in Q4 2015 and held it in 7 quarters. The position peaked at $921K in Q3 2016. 355 funds tracked by Wall St. Rank hold SYNH as of Q3 2021.

  • Walleye Trading reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
  • Walleye Trading sold 799 Syneos Health, Inc. Class A Common Stock shares in Q3 2021, an estimated $72.3K.
  • Walleye Trading first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 7 quarters.
  • Walleye Trading's Syneos Health, Inc. Class A Common Stock position peaked at $921K in Q3 2016.
  • 355 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2021.

Based on Walleye Trading's 13F filing for Q3 2021, filed 15 Nov 2021.